THE EFFICACY OF INTRA-SINUS POVIDONE-IODINE/BUDESONIDE GEL FORMING SUSPENSION FOLLOWING ENDOSCOPIC SINUS SURGERY FOR CHRONIC RHINOSINUSITIS: A RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED TRIAL

Registry ID

H24-02473

Source registry

HEALTH_CANADA

Status

Ongoing

Study type

INTERVENTIONAL

Sponsor

ST PAULS HOSPITAL VANCOUVER

Start date

2026-06-01

Last update

2025-10-09

Conditions

• RHINOSINUSITIS

Related clinical trials

• A DOUBLE-BLINDED EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY AND TOLERABILITY OF ITEPEKIMAB IN ADULT PARTICIPANTS WITH INADEQUATELY CONTROLLED CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (CRSWNP) WHO PARTICIPATED IN EITHER EFC18418 OR EFC18419 CLINICAL STUDIES
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, 52-WEEK PHASE 3 TRIAL TO INVESTIGATE THE EFFICACY, SAFETY, AND TOLERABILITY OF ITEPEKIMAB IN ADULT PARTICIPANTS WITH INADEQUATELY-CONTROLLED CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, 52-WEEK PHASE 3 TRIAL TO INVESTIGATE THE EFFICACY, SAFETY, AND TOLERABILITY OF ITEPEKIMAB IN ADULT PARTICIPANTS WITH INADEQUATELY-CONTROLLED CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
• OPENING THE 'BLACK BOX' ON TEZEPELUMAB'S EFFECT OF CHRONIC RHINOSINUSITIS WITH SEVERE ASTHMA
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF-OF-CONCEPT (POC) STUDY TO ASSESS THE EFFICACY, SAFETY, AND TOLERABILITY OF ITEPEKIMAB IN PARTICIPANTS WITH INADEQUATELY CONTROLLED CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPS
• A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LEBRIKIZUMAB/LY3650150 IN ADULT PARTICIPANTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPS ON BACKGROUND INTRANASAL CORTICOSTEROIDS

View on source registry